학술논문

Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2–3 trial
Document Type
Article
Source
In The Lancet Oncology March 2017 18(3):357-370
Subject
Primary Research
Articles
Language
ISSN
1470-2045